4-(Dimethylamino)-2-(4-methyl-3-nitrophenylamino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)pyrimidine-5-carboxamide

ID: ALA3781168

Chembl Id: CHEMBL3781168

PubChem CID: 122633885

Max Phase: Preclinical

Molecular Formula: C29H26F3N7O4

Molecular Weight: 593.57

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(Nc2ccc(C)c([N+](=O)[O-])c2)nc1N(C)C

Standard InChI:  InChI=1S/C29H26F3N7O4/c1-16-8-10-20(34-26(40)18-6-5-7-19(12-18)29(30,31)32)13-23(16)36-27(41)22-15-33-28(37-25(22)38(3)4)35-21-11-9-17(2)24(14-21)39(42)43/h5-15H,1-4H3,(H,34,40)(H,36,41)(H,33,35,37)

Standard InChI Key:  XGGZGPUHUFLDEN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3781168

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Transcription factor ETV6/Tyrosine-protein kinase ABL1 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 593.57Molecular Weight (Monoisotopic): 593.1998AlogP: 6.33#Rotatable Bonds: 8
Polar Surface Area: 142.39Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.66CX Basic pKa: 4.41CX LogP: 6.90CX LogD: 6.90
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.16Np Likeness Score: -1.93

References

1. Liang X, Liu X, Wang B, Zou F, Wang A, Qi S, Chen C, Zhao Z, Wang W, Qi Z, Lv F, Hu Z, Wang L, Zhang S, Liu Q, Liu J..  (2016)  Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.,  59  (5): [PMID:26789553] [10.1021/acs.jmedchem.5b01618]

Source